Enveric Biosciences ENVB
NASDAQ ENVB
$1.38 -0.01 (-0.71%)
As of: Aug 21, 2026 · 10:33 AM EDT

Enveric Biosciences (ENVB) FCF Margin Growth (5y) (2019 - 2020)

Enveric Biosciences (ENVB) FCF Margin Growth (5y) (2019 - 2020) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.95 Bn 132.10 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.71 Bn 78.72 Bn 3.93 Bn
3 Argenx Se 65.71 Bn 60.52 Bn 1.37 Bn
4 Moderna 60.45 Bn 55.31 Bn 52.00 Mn
5 BeOne Medicines 42.24 Bn 37.14 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.80 Bn 28.49 Bn 992.69 Mn
7 BioNTech SE 28.64 Bn 10.25 Bn 668.28 Mn
8 Insmed 27.61 Bn 26.45 Bn 358.27 Mn
9 Royalty Pharma 27.26 Bn 26.42 Bn -
10 Enveric Biosciences 5.50 Mn -2.79 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2020 6,807.00
Jun 30, 2020 1,721.00
Mar 31, 2020 -204.00
Jun 30, 2019 -1,042.00